Related Experiment Video
Updated: May 7, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Digital twins for cardiopulmonary medicine: the case for pulmonary arterial hypertension
Steven A Niederer1,2, Maximilian Balmus1,2, Christopher Burr1
1The Alan Turing Institute, London, United Kingdom.
Abstract:
The management of pulmonary arterial hypertension (PAH), like so many diseases, currently relies on episodic data from clinic visits, which offers limited insight into a patient's disease trajectory and dynamic clinical decisions. Patient digital twins present a technological solution that combines hospital and community data into a single dynamic and predictive virtual representation of the patient. Digital twins operationalize real-world observational inference at the individual level, functioning as a complementary decision-support tool alongside trial evidence. This review introduces the concept of a patient digital twin and provides a roadmap for the development, evaluation, and potential implementation of a patient digital twin for PAH. The resulting twin has the potential to change PAH care pathways, shifting PAH care from reactive to proactive management.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy II: Dilated Cardiomyopathy
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

